Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
주식 순위 #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
주가
$0.6
마지막 동기화: 2024-08-14
시가총액
$2.09M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
SG
거래 ASLAN Pharmaceuticals Limited (ASLN)

카테고리

ASLAN Pharmaceuticals Limited (ASLN)의 주식 분할 이력
ASLAN Pharmaceuticals Limited 주식 (심볼: ASLN)은 총 2회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jul 03, 2024에 발생했습니다.
Mar 13, 2023 이전에 매수한 ASLN 주식 1주는 현재 0.025주의 ASLN 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2024-07-03 1:8 x0.125 x0.025
2023-03-13 1:5 x0.2 x0.2
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE